24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Atox Bio
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
15:02
Eddie and I: Israeli project at Venice Film Festival teaches sign language through VR
13:44
Quantum computing sparks real estate race
13:36
As EU weighs limits on Israeli research, Poland offers support to Startup Nation
09:01
Gaza protesters occupy Microsoft President’s office, forcing HQ lockdown
More stories
Buzz
Most popular
Daily
Weekly
1
Okta acquires Israeli cyber startup Axiom in $100 million deal
2
"I achieved the Holy Grail: I built software that builds software"
3
Why OpenAI and xAI angels are betting on Israeli AI startup Tzafon
4
Israeli Entrepreneur Aviv Tzidon Wants to Take Part in the Electric Revolution
5
Thoma Bravo closing on $2 billion acquisition of Verint
More news
Atox Bio
2 stories about Atox Bio
CTech’s Daily Israeli Tech News Roundup
04.12.17
|
CTech
Bank of China partners with Israeli bank to finance Israeli companies in China. Medinol receives FDA approval for the drug-eluting stent. Israel plans solar energy push
Adams Street Partners Backs Critical Care Treatment Startup Atox Bio
04.12.17
|
Lilach Baumer
The company's leading product is currently being tested in clinical trials for the treatment of flesh-eating bacteria and kidney failure